Philip Van Damme
Philip Van Damme
Professor of Neuroscience, University of Leuven
Geverifieerd e-mailadres voor uzleuven.be
Titel
Geciteerd door
Geciteerd door
Jaar
EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)–revised report of an EFNS task force
EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis:
European journal of neurology 19 (3), 360-375, 2012
6052012
Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS
E Storkebaum, D Lambrechts, M Dewerchin, MP Moreno-Murciano, ...
Nature neuroscience 8 (1), 85-92, 2005
5442005
The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis
L Van Den Bosch, P Van Damme, E Bogaert, W Robberecht
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1762 (11-12 …, 2006
4322006
HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1–induced Charcot-Marie-Tooth disease
C d'Ydewalle, J Krishnan, DM Chiheb, P Van Damme, J Irobi, ...
Nature medicine 17 (8), 968-974, 2011
3742011
Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival
P Van Damme, A Van Hoecke, D Lambrechts, P Vanacker, E Bogaert, ...
The Journal of cell biology 181 (1), 37-41, 2008
3482008
Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs
J Jiang, Q Zhu, TF Gendron, S Saberi, M McAlonis-Downes, A Seelman, ...
Neuron 90 (3), 535-550, 2016
2522016
EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans
A Van Hoecke, L Schoonaert, R Lemmens, M Timmers, KA Staats, ...
Nature medicine 18 (9), 1418-1422, 2012
2492012
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
W Van Rheenen, A Shatunov, AM Dekker, RL McLaughlin, FP Diekstra, ...
Nature genetics 48 (9), 1043-1048, 2016
2482016
Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study
A Shatunov, K Mok, S Newhouse, ME Weale, B Smith, C Vance, ...
The Lancet Neurology 9 (10), 986-994, 2010
2232010
Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity
P Van Damme, E Bogaert, M Dewil, N Hersmus, D Kiraly, W Scheveneels, ...
Proceedings of the National Academy of Sciences 104 (37), 14825-14830, 2007
2152007
Phase Separation of C9orf72 Dipeptide Repeats Perturbs Stress Granule Dynamics
S Boeynaems, E Bogaert, D Kovacs, A Konijnenberg, E Timmerman, ...
Molecular cell 65 (6), 1044-1055. e5, 2017
2122017
Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues
M Delforge, J Bladé, MA Dimopoulos, T Facon, M Kropff, H Ludwig, ...
The lancet oncology 11 (11), 1086-1095, 2010
2112010
Serum biomarker for progranulin‐associated frontotemporal lobar degeneration
K Sleegers, N Brouwers, P Van Damme, S Engelborghs, I Gijselinck, ...
Annals of Neurology: Official Journal of the American Neurological …, 2009
1902009
The C9ORF72 expansion mutation is a common cause of ALS+/− FTD in Europe and has a single founder
BN Smith, S Newhouse, A Shatunov, C Vance, S Topp, L Johnson, ...
European Journal of Human Genetics 21 (1), 102-108, 2013
1842013
Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis
MA Van Es, HJ Schelhaas, PWJ Van Vught, N Ticozzi, PM Andersen, ...
Annals of neurology 70 (6), 964-973, 2011
1652011
Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis
T Philips, A Bento-Abreu, A Nonneman, W Haeck, K Staats, V Geelen, ...
Brain 136 (2), 471-482, 2013
1642013
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind …
JF Howard Jr, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, ...
The Lancet Neurology 16 (12), 976-986, 2017
1612017
Excitotoxicity and amyotrophic lateral sclerosis
P Van Damme, M Dewil, W Robberecht, L Van Den Bosch
Neurodegenerative diseases 2 (3-4), 147-159, 2006
154*2006
Genome-wide analyses identify KIF5A as a novel ALS gene
A Nicolas, KP Kenna, AE Renton, N Ticozzi, F Faghri, R Chia, ...
Neuron 97 (6), 1268-1283. e6, 2018
1532018
Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration
K Poesen, D Lambrechts, P Van Damme, J Dhondt, F Bender, N Frank, ...
Journal of Neuroscience 28 (42), 10451-10459, 2008
1502008
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20